Type 2 myocardial infarction: the potential for early detection

Aim. To evaluate the potential of using factors associated with type 2 myocardial infarction (MI) for its early diagnosis.

Material and methods. This prospective study included 204 patients diagnosed with acute coronary syndrome (ACS). At the time of admission, each patient underwent standard examinations for ACS patients. The 1-year stage consisted of telephone survey of patients on the course of long-term postinfarction period. There were following endpoints: death, recurrent coronary events and hospitalization.

Result. Patients with type 2 MI accounted for 10,8% (n=22) of the entire analyzed sample. A model for prehospital diagnosis of probable type 2 MI has been developed. The model included clinical and history data that allow to suggest the type 2 MI course without invasive and laboratory studies. The model included signs (body mass index ≥35, kg/m², atrial fibrillation+Killip I, hemoglobin <110 g/l within 1 year before MI, chronic obstructive pulmonary disease), the most common in type 2 MI patients according to own data and previous studies.

Conclusion. A model of prehospital clinical assessment of MI risk has been developed for making a preliminary diagnosis and forming different patient streams at the admission stage for the final verification of the diagnosis.

1. Thygesen K, Alpert JS, Jaffe AS, et al. Fourth universal definition of myocardial infarction. 2018. Circulation. 2018;138(20):e618-51. doi:10.1161/CIR.0000000000000617.

2. Reznik EV, Golubev YY, Mikhaleva LM. Diagnostics and management of patients with type 2 myocardial infarction. Consilium Medicum. 2021;23(10):765-71. (In Russ.) doi:10.26442/20751753.2021.10.201129.

3. Hawatmeh A, Thawabi M, Aggarwal R, et al. Implications of misclassification of type 2 myocardial infarction on clinical outcomes. Cardiovasc Revasc Med. 2019;21(2):176-9. doi:10.1016/j.carrev.2019.04.009.

4. McCarthy CP, Kolte D, Kennedy KF, et al. Hospitalizations and Outcomes of T1MI Observed Before and After the Introduction of MI Subtype Codes. J Am Coll Cardiol. 2021;78(12):1242-53. doi:10.1016/j.jacc.2021.07.034.

5. Averkov OV, Barbarash OL, Boytsov SA, et al. Differentiated approach in diagnostics, diagnosis formulation, case management and statistical accounting of type 2 myocardial infarction. Russian Journal of Cardiology. 2019;(6):7-21. (In Russ.) doi:10.15829/1560-4071-2019-6-7-21.

6. Oblavatckii DV, Boldueva SA, Soloveva MV, et al. The Frequency of Type 2 Myocardial Infarction in the Structure of Hospital Mortality According to 7-Years Data of a State University Clinic. Kardiologiia. 2020;60(6):76-83. (In Russ.) doi:10.18087/cardio.2020.6.n896.

7. Barbarash OL. Clinical significance of the diagnosis of myocardial infarction type 2. Creative cardiology. 2019;13(4):297-307. (In Russ.) doi:10.24022/1997-3187-2019-13-4-297-307.

8. Zharskiy SL. Type 2 myocardial infarction: the current state of the problem. Far East Medical J. 2016;3:134-8. (In Russ.)

9. Kinash VI, Vorobev AS, Urvantseva IA, et al. Controversial issues of type 2 myocardial infarction patients management. Complex Issues of Cardiovascular Diseases. 2022;11(1):78-89. (In Russ.) doi:10.17802/2306-1278-2022-11-1-78-89.

10. Pecherina TB, Kashtalap VV. Clinical examples of various types of myocardial infarction from the standpoint of choosing optimal approaches to secondary prevention. Creative cardiology. 2019;13(4):363-74. (In Russ.) doi:10.24022/1997-3187-2019-13-4-363-374.

11. Musher DM, Abers MS, Corrales-Medina VF. Acute infection and myocardial infarction. N Engl J Med. 2019;380(2):171-6. doi:10.1056/NEJMra1808137.

12. Guimaraes PO, Leonardi S, Huang Z, et al. Tricoci Clinical features and outcomes of patients with type 2 myocardial infarction: Insights from the Thrombin Receptor Antagonist for Clinical Event Reduction in Acute Coronary Syndrome (TRACER) trial. Am Heart J. 2018;196:28-35. doi:10.1016/j.ahj.2017.10.007.

13. Claire ER, Roger VL, Sandoval Y, et al. Bell Causes of Death After Type 2 Myocardial Infarction and Myocardial Injury. J Am Coll Cardiol. 2021;78(4):415-6. doi:10.1016/j.jacc.2021.05.026.